Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure
Authors:
- Jean-Damien RicardJRJean-Damien Ricard
- ContributorsCOContributors
- Dan LongroisDLDan Longrois
- Didier DreyfussDDDidier Dreyfuss
- 15 July 2020
- journal article
- letter
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (10) , 1924-1926
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- COVID-19 patients with respiratory failure: what can we learn from aviation medicine?British Journal of Anaesthesia, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Medicine, 2020
- Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)Intensive Care Medicine, 2020
- An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2019